Multimodality assessment of brain tumors and tumor recurrence.
about
Magnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentationThe use of dynamic nuclear polarization (13)C-pyruvate MRS in cancerEmerging methods for disease monitoring in malignant gliomasQuantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model.Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationPET/MRI for neurologic applications.Molecular Imaging Using Endogenous Cellular Proteins.Proton MRS imaging in pediatric brain tumors.¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumorsQuantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat modelIntegrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas.Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.PORTR: Pre-operative and post-recurrence brain tumor registrationMolecular brain imaging in the multimodality era.Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner.[(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brainPilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approachDiagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors.Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.Translation of the ecological trap concept to glioma therapy: the cancer cell trap conceptOptimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.Image coregistration: quantitative processing framework for the assessment of brain lesions.Diapeutic cancer-targeting alkylphosphocholine analogs may advance management of brain malignancies.Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study.Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.Contribution of susceptibility- and diffusion-weighted magnetic resonance imaging for grading gliomas.Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.
P2860
Q24187505-330F3A69-3E5F-422C-9C14-B68BEE4C9695Q26778444-71C5D79F-1AEF-47BF-B81F-24FBF24CAA82Q27023823-3F492637-2C60-4281-95BB-85460E132183Q30377881-C7E7B79F-754B-448D-8C7D-0E615E628BFEQ30575110-F92B144C-1578-4F18-A5B5-6E0942018BFFQ30577115-503C9A6C-CB5B-4709-9DAB-E3032D1316ADQ30856242-0C0D6A41-A62F-4DD9-BFC1-15DF9F059B9DQ31103164-33FFDC4E-4CFD-46A8-AD37-6A35B3096D62Q33560943-D249BC72-4300-48D7-AF87-090C644B087CQ33616603-CFC71A7B-B626-4281-979E-AAC7819D7647Q33753445-506B68AB-580A-4022-A7A5-667CCF7717B1Q33894461-8FC7E79D-1EDA-45BA-A0D1-901D612FE690Q34049922-0F6ADC16-A777-43BD-8D78-56A68871660FQ34204125-1B8E4226-01E3-41A7-A63D-E5D352CC3534Q34344365-DC660F97-99F4-48BE-850F-1A92FF95E57BQ34987705-44003FD4-E266-49E6-A5F4-C0F762D5ED21Q35760788-5E716843-467D-452D-B59A-AED460A7C792Q35829589-04112B68-BAE0-49A7-8A73-14000AE02184Q35927273-6F399083-4A76-4C5C-94EB-2A632BE0DEC4Q36035112-8A22C19E-438A-49D5-8B37-928813096019Q36250739-C98A7489-F24A-466F-8225-C72FE25639E3Q36530795-4C36A8CB-8EC5-40D9-83A6-6C6BED8ADD23Q37494311-0327ED53-BA11-424F-973C-CBDFE4AE7EA2Q38656133-9CB6E00B-E290-4A9B-AC96-5EB46A5129A1Q38950411-0EF1AF43-E8FF-42A2-AA12-9C00EAF896F0Q39017777-C2B0CF3E-2231-418F-A39B-823C2FEBEF53Q39031636-5F9F5879-3F00-481E-B97A-B41934D25E91Q39751883-81E3C203-B963-4F5D-9829-E4C8BE1B4B07Q41638130-D5C972A1-8132-4C0F-81EA-9EE309598C60Q41994160-B7CBF75C-52A5-40E2-A7E6-D7EEEEF85709Q42362580-EF765C58-C106-4A7D-B1A8-FDD533E282A7Q47402888-217D8D90-243B-4CCC-8F4A-BCDE762356B0Q48158155-7ADBA072-E6BF-4587-BA34-A00E15442BD2Q48246048-0E73B61A-6956-4293-A6D1-5BE21576F6FDQ48665122-53863208-0504-4384-8E46-E6A6CBD0F142Q55370680-B10B5AD6-C96E-4357-8FD2-C6B8841B88ABQ55388033-0C84832A-61E6-457F-9DDA-AACAB74B5755
P2860
Multimodality assessment of brain tumors and tumor recurrence.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Multimodality assessment of brain tumors and tumor recurrence.
@ast
Multimodality assessment of brain tumors and tumor recurrence.
@en
type
label
Multimodality assessment of brain tumors and tumor recurrence.
@ast
Multimodality assessment of brain tumors and tumor recurrence.
@en
prefLabel
Multimodality assessment of brain tumors and tumor recurrence.
@ast
Multimodality assessment of brain tumors and tumor recurrence.
@en
P2093
P1476
Multimodality assessment of brain tumors and tumor recurrence.
@en
P2093
Heinrich Lanfermann
Peter Raab
Wolf-Dieter Heiss
P304
P356
10.2967/JNUMED.110.084210
P407
P577
2011-08-12T00:00:00Z